Anti-tumor activity of the novel hexahydrocannabinol analog LYR-8 in Human colorectal tumor xenograft is mediated through the inhibition of Akt and hypoxia-inducible factor-1α activation.

Cancer (Colon)

Key Findings

LYR-8 (Hexahydrocannabinol analog)) may function as an anti-tumor agent against colorectal cancer line.

Information and Links


Link: Anti-tumor activity of the novel hexahydrocannabinol analog LYR-8 in Human colorectal tumor xenograft is mediated through the inhibition of Akt and hypoxia-inducible factor-1α activation.

Year: 2012

DOI: 22687485


Ratings

(How Ratings Work)

Cancer (Colon) — 1


Possibility of efficacy for cannabis in treatment of Cancer (Colon) according to the results found in this study.

Drugs Used

Hexahydrocannabinol